Hemorrhoids in pregnant and postpartum women: risk factors

Cover Page

Cite item

Abstract

Objective. To investigate the main risk factors and symptoms of hemorrhoids in maternity patients in the postpartum department of the PC of the Saratov region for the period from 2021 to 2022 by means of anonymous questionnaire.

Materials and methods. Patients were categorized into 3 groups according to receipt of progesterone therapy during the last pregnancy: In Group I, pregnant and postpartum women did not receive hormonal therapy (n=114). Group II included pregnant and postpartum women who received progesterone during their pregnancy for not more than 1 trimester (n=64). Group III consisted of pregnant and postpartum women whose pregnancy resulted from IVF. They received progesterone therapy for 2 or more trimesters (n=36).

Results. The study revealed that hemorrhoid symptoms were statistically more frequent in the women from group III, who had received progesterone hormone therapy for more than 2 trimesters. The most significant risk factors for the development of hemorrhoids in pregnant and postpartum women were: natural delivery: the number of births 3 and more; prolonged gestagens intake; tendency to constipation; positive family history of hemorrhoidal and varicose diseases.

Conclusions. Unfortunately, hemorrhoids in pregnant and postpartum women is still an urgent problem of interdisciplinary control of proctologic complaints in pregnant and postpartum women. Most physicians do not give recommendations on the present symptomatology in women.

Full Text

Introduction

Pregnancy is a unique condition for the female body, associated with the risk of developing various diseases. Gestational diabetes, gestosis, and other dangerous conditions pose a threat to the life of both mother and fetus [1]. Prevention and treatment of such pregnancy complications are the responsibility of the antenatal clinic, where, a pregnant woman will be examined by an obstetrician-gynecologist, a general practitioner, an ophthalmologist, an otolaryngologist and a dentist. Visits to other specialists are made as needed, taking into account any associated pathologies.

Hemorrhoidal disease, unlike the conditions mentioned above, can develop in anyone. Hemorrhoidal plexuses provide the primary functions of the rectum: fecal retention and defecation. The main factors that contribute to pathology during pregnancy include: hormonal imbalances (hyperprogesteronemia); functional disorders of the venous walls; increased intra-abdominal pressure; and increased circulating blood volume [2]. Hemorrhoids most often develop in the third trimester of pregnancy, as this period is characterized by the maximum impact of all pathogenesis factors. Progesterone, as the main pregnancy hormone, also affects the smooth muscles of the venous wall and intestines, causing them to relax. An increase in circulating blood volume and increased intra-abdominal pressure contribute to this. The combination of these factors negatively impacts blood circulation in the cavernous bodies [3; 4]. Hemorrhoids most often develop in the third trimester of pregnancy, as this period is characterized by the maximum impact of all links in the pathogenesis [5].

Developing hemorrhoidal hyperplasia leads to symptoms such as itching, burning, pain, bleeding, and the appearance of a tumor-like formation in the anorectal area. The physiological conditions of pregnancy and childbirth can be considered as separate risk factors for the development of hemorrhoids. Hemorrhoid symptoms are more common in pregnant women than in non-pregnant women [6].

Hemorrhoids are a common anorectal disorder, representing a serious medical and socioeconomic problem. Pregnancy, while not a primary pathogenic factor for hemorrhoids, often contributes to the underlying risk factors for hemorrhoidal disease [7–9]. According to some studies, the incidence of hemorrhoids among pregnant and postpartum women ranges from 15 to 41 %, and in some populations up to 85 %. An increase in prevalence has been noted with increasing age and parity of births [10; 11].

It should be clarified that hemorrhoids do not pose a direct threat to the life of the mother and fetus, but they can significantly worsen the quality of life of pregnant women and women in labor [12]. Constant itching, pain, and bleeding negatively affect a woman's psycho-emotional state, disrupting her moral and physical comfort and complicating her relationship with the newborn [13].

The threat to motherhood requires us to conduct a more detailed study of this issue for better diagnosis and treatment. An objective assessment of the prevalence of hemorrhoids among pregnant and postpartum women is complicated by the sensitivity and intimacy of the problem, as women often fail to mention such complaints to their physician, leading to serious consequences.

The aim of the study is to investigate the main risk factors and symptoms of hemorrhoids in women in labor in the postpartum department of the perinatal center of the Saratov region for the period 2021–2022 through an anonymous survey.

Materials and Methods

The main factors in the development of hemorrhoids during pregnancy include: hormonal imbalances (hyperprogesteronemia); functional disorders of the venous walls; increased intra-abdominal pressure; and increased circulating blood volume. It is important to note that hemorrhoids most often develop in the third trimester of pregnancy, as this period is characterized by the maximum impact of all pathogenesis factors. The study involved 214 people.

The criteria for inclusion in the study were: singleton pregnancy; absence of severe forms of extragenital pathology; absence of hemorrhoidal disease before pregnancy; patient age from 25 to 40 years; absence of gastrointestinal tract (GIT) tumors in patients; voluntary informed consent for the study.

Criteria for exclusion from the study: multifetal pregnancy; presence of severe forms of extragenital pathology; age of patients under 25 and over 40; gastrointestinal tumors in patients.

In the study, patients were divided into three groups based on whether they had received progesterone therapy during their last pregnancy. In Group I, women in labor did not receive hormonal therapy (n = 114). Group II included women in labor who received progesterone during pregnancy (n = 64). Group III includes women in labor whose pregnancy occurred as a result of IVF (n = 36). Utrozhestan and Duphaston were taken by the patients during their last pregnancy as progesterone preparations. In Group II, 71.9 % they took Utrozhestan, 28.1 % took Duphaston. In Group III, all patients took Utrozhestan. Patients in Group III received longer-term hormonal therapy (Table 1).

It's worth noting that vaginal delivery is also a predisposing factor for the development of hemorrhoids. We noted that vaginal delivery was more common in groups I and II. When examining the pathologies of the last pregnancy, we found that vomiting during pregnancy was prevalent in Group III; the threat of miscarriage was detected in all groups of patients; patients in Groups II and III received hormonal therapy.

Nonparametric analysis methods were used for statistical data processing. The Kruskal-Wallis test was used to assess the significance of differences, and the Mann-Whitney test was used for subsequent pairwise comparisons. The critical significance level (p-value) was set to 0.05. The study was conducted in accordance with Good Clinical Practice standards and the principles of the Declaration of Helsinki.

 

Table 1. The nature of hormonal therapy

Treatment of female patients

Characteristics of the course of the last pregnancy

Group 1

(n = 114),

abs. (%)

Group 2

(n = 64),

abs. (%)

Group 3

(n = 36),

abs. (%)

p

Taking iron supplements during their last pregnancy

50 (43.8)

42 (65.6)

18 (50)

p1 = 0.006

p2 = 0.519

p3 = 0.126

Taking hormonal therapy aimed at maintaining pregnancy

0 (0)

64 (100)

36 (100)

p1 < 0.001

p2 < 0.001

p3 = 1.000

Type of hormonal therapy

Utrozhestan

0 (0)

46 (71.9)

36 (100)

p1 < 0.001

p2 = 0.001

p3 = 1.000

Duphaston

0 (0)

18 (28.1)

0 (0)

p1 = < 0.001

p2 = 1.000

p3 = < 0.001

Trimester in which the patient received hormonal therapy

First trimester only

0 (0)

41 (64)

0 (0)

p1 = < 0.001

p2 = 1.000

p3 = < 0.001

Second trimester only

0 (0)

15 (23.4)

0 (0)

p1 = < 0.001

p2 = 1.000

p3 = < 0.003

Third trimester only

0 (0)

8 (13.6)

0 (0)

p1 = 0.003

p2 = 1.000

p3 = 0.086

Through two or more trimesters

0 (0)

0 (0)

36 (100)

p1 < 0.001

p2 < 0.001

p3 < 0.001

 

Results And Discussion

As can be seen from the data in Table 2, in all three groups, the majority of women had one or two previous pregnancies and one or two previous births. When collecting the history of extragenital pathology, the presence of varicose veins of the lower extremities was emphasized. This pathology occurred in 12 women (10.5 %) in Group I, 7 women (10.9 %) in Group II, and 2 women (5.6 %) in Group III.

The characteristics of the course of the last pregnancy are presented in Table 3 and Fig. 1. In Group I, the predominant method of delivery was vaginal delivery (91.2 %), while in Group III, all patients were delivered by cesarean section (100 %).

Patients were asked to subjectively assess the presence and severity of nausea and vomiting. As shown in Table 4, symptoms were present in half of the patients in Groups I and II, as well as in almost 80 % of patients in Group III. Threatened miscarriage was reported in 12 women (10.5 %) in Group I, 28 (43.8 %) in Group II, and 10 (27.7 %) in Group III.

When assessing the risk factors for the development of hemorrhoids (Table 5), it was determined: 1) based on the data of heredity analysis, the presence of varicose veins of the lower extremities and/or hemorrhoidal disease in first-degree relatives was revealed in 78 (68.4 %) women in group I, 46 (71.9 %) in group II, and 28 (77.8 %) in group III; 2) predisposing or resolving factors for hemorrhoids are insufficient amounts of dietary fiber in the diet.

 

Table 2. Gynecological history and presence of extragenital pathology

Anamnesis of life

Group 1

(n = 114), abs. (%)

Group 2

(n = 64), abs. (%)

Group 3

(n = 36), abs. (%)

р

Gynecological history

Number of pregnancies in the medical history (including the last pregnancy)

0–1

66 (57.8)

30 (46.8)

26 (72.1)

p1 = 0.157

p2 = 0.124

p3 = 0.015

3–4

30 (26.2)

22 (34.3)

10 (27.7)

p1 = 0.257

p2 = 0.863

p3 = 0.498

5–6

18 (15.8)

10 (15.6)

0 (0)

p1 = 0.977

p2 = 0.012

p3 = 0.013

7 and more

0 (0)

2 (3.1)

0 (0)

p1 = 0.058

p2 = 1.000

p3 = 0.284

Number of births (including the most recent births)

1–2

80 (70.2)

42 (65.6)

36 (100)

p1 = 0.531

p2 < 0.001

p3 < 0.001

3–4

34 (29.7)

12 (34.3)

0 (0)

p1 = 0.036

p2 < 0.001

p3 = 0.013

Extragenital pathology

Varicose veins of the lower extremities

12 (10.5)

7 (11)

2 (5.6)

p1 = 0.933

p2 = 0.372

p3 = 0.367

 

Table 3. Characteristics of the course of the last pregnancy

Characteristics of the course of the last pregnancy

Group 1

(n = 114), abs. (%)

Group 2

(n = 64), abs. (%)

Group 3

(n = 36), abs. (%)

p

The deadline for registering at the antenatal clinic

First trimester

99 (86.8)

58 (90.6)

36 (100)

p1 = 0.453

p2 = 0.022

p3 = 0.059

Second trimester

15 (13.2)

6 (9.4)

0 (0)

p1 = 0.453

p2 = 0.022

p3 = 0.059

Third trimester

0 (0)

0 (0)

0 (0)

p1 = 1.000

p2 = 1.000

p3 = 1.000

Method of delivery in the last pregnancy

Cesarean section

10 (8.7)

16 (25)

36 (100)

p1 = 0.004

p2 < 0.001

p3 < 0.001

Natural

104 (91.2)

48 (75)

0 (0)

p1 = 0.004

p2 < 0.001

p3 < 0.001

 

Fig. 1. Method of delivery in patients of groups I–III

 

The patients were asked to estimate the proportion of their daily diet consisting of fruits and vegetables. It is noteworthy that approximately half of the women in Groups I and II had no more than 10 % fiber in their diet. Meanwhile, for 72 % of patients in Group III, fruits and vegetables comprised between 10 % and 40 % of their daily diet.

Table 6 presents the risk factors for hemorrhoid development associated with defecation. About half of the patients in all three groups spent more than 5 minutes in the toilet. As a means of personal hygiene after defecation, patients in Groups I and II most often used toilet paper – 46 (40.4 %) and 32 (50 %), respectively. In group III, patients use toilet paper (14 (38.9 %)) and intimate washing (16 (44.4 %)) with almost equal frequency).

Next, the patients were asked questions to identify symptoms of hemorrhoids (Fig. 2). Regardless of the group, the most common symptom during the last pregnancy for women was a feeling of fullness in the rectum without the urge to defecate: in Group I – 42 (36.8 %) women, in Group II – 32 (50 %), in Group III - 26 (72,2 %). The second most common symptom experienced by women in labor was an extuberance in the anus: 30 (26.3 %) in Group I, 20 (31.3 %) in Group II, and 20 (55.5 %) in Group III. It's important to note that hemorrhoid symptoms were most common in patients whose pregnancies were achieved through IVF. Itching, burning, and pain in the anus were reported by 12 (33.3 %) of them, and blood on toilet paper by 10 (27,7 %).

During the study, it was also noted that these symptoms of hemorrhoids did not bother the majority of patients (in Group I there were 66 (57.9 %) women, in Group II – 38 (59.4 %), in Group III – 26 (72.2 %)) before the current pregnancy (Table 7).

 

Table 4. Pathology of the last pregnancy

Characteristics of the course of the last pregnancy

Group 1

(n = 114), abs. (%)

Group 2

(n = 64), abs. (%)

Group 3

(n = 36), abs. (%)

p

Vomiting of pregnant (according to the subjective assessment of patients)

There was no vomiting

56 (49.1)

32 (50)

8 (22.2)

p1 = 0.911

p2 = 0.005

p3 = 0.007

Minor (nausea, vomiting 1-2 times in the morning, lasting no more than one trimester)

36 (31.6)

12 (18.8)

12 (33.3)

p1 = 0.065

p2 = 0.845

p3 = 0.102

Moderate (nausea, vomiting 3-5 times a day, lasting no more than one trimester)

12 (10.5)

14 (21.9)

10 (27.7)

p1 = 0.040

p2 = 0.011

p3 = 0.508

Significantly impaired quality of life (nausea, vomiting more than 5 times a day, lasting more than one trimester)

10 (8.7)

6 (9.4)

6 (16.6)

p1 = 0.893

p2 = 0.181

p3 = 0.282

Threat of termination of pregnancy

12 (10.5)

28 (43.8)

10 (27.7)

p1 < 0.001

p2 = 0.011

p3 = 0.115

 

Table 5. Risk factors for hemorrhoids occurrence

Risk factors for hemorrhoids occurrence

Group 1

(n = 114), abs. (%)

Group 2

(n = 64), abs. (%)

Group 3

(n = 36), abs. (%)

p

Heredity

Varicose and/or hemorrhoidal disease in first-degree relatives

78 (68.4)

46 (71.9)

28 (77.8)

p1 = 0.631

p2 = 0.283

p3 = 0.519

Diet

The amount of vegetables and fruits in the diet (according to the subjective assessment of patients)

Up to 10% of the daily diet

56 (49.1)

38 (59.4)

8 (22.2)

p1 = 0.189

p2 = 0.005

p3 < 0.001

From 10% to 40% of the daily diet

38 (33.3)

16 (25)

26 (72.2)

p1 = 0.246

p2 < 0.001

p3 < 0.001

More than 40% of the daily diet

20 (17.5)

10 (15.6)

2 (5.6)

p1 = 0.743

p2 = 0.077

p3 = 0.137

 

The issues of intimacy and delicacy of the problem were considered and are reflected in Table 8. As the study shows, only no more than 1/3 of the patients had previously been examined by a proctologist in each group. Due to the intimacy of the problem, according to our data, patients more often turn to female proctologists for this problem than to male ones (statistically confirmed by mathematical processing of the results). But it is worth noting that patients in all groups have a sober assessment of the problem of the possible occurrence of hemorrhoids and in most cases would agree to surgical intervention to eliminate the disease.

 

Table 6. Characteristics of the act of defecation

Parameter

Group 1

(n = 114), abs. (%)

Group 2

(n = 64), abs. (%)

Group 3

(n = 36), abs. (%)

p

Frequency of defecation

1-2 times a day

92 (80.7)

60 (93.9)

28 (77.8)

p1 = 0.019

p2 = 0.703

p3 = 0.019

Once every 3 days

16 (14)

0 (0)

4 (11.1)

p1 = 0.002

p2 = 0.653

p3 = 0.007

Less than once every 3 days

6 (5.3)

4 (6.35)

4 (11.1)

p1 = 0.784

p2 = 0.221

p3 = 0.390

Defecation at the same time

36 (31.6)

32 (50)

22 (61.1)

p1 = 0.016

p2 = 0.002

p3 = 0.285

The patient takes a phone/book to the toilet

40 (35.1)

12 (18.8)

18 (50)

p1 = 0.022

p2 = 0.110

p3 = 0.002

The patient spends more than 5 minutes on the toilet

60 (52.6)

26 (40.6)

16 (44.4)

p1 = 0.124

p2 = 0.392

p3 = 0.711

Patients use after defecation

Toilet paper

46 (40.4)

32 (50)

14 (38.9)

p1 = 0.214

p2 = 0.876

p3 = 0.285

Wet wipes

32 (28.1)

14 (21.9)

6 (16.7)

p1 = 0.365

p2 = 0.171

p3 = 0.532

 

Intimate washing

36 (31.8)

30 (28.1)

16 (44.4)

p1 = 0.043

p2 = 0.158

p3 = 0.815

 

Fig. 2. Characteristics of hemorrhoid symptoms among women in labor, % of the number in the group

 

Fig. 3. Distribution of hemorrhoid symptoms among women in labor, %

 

Women in labor were also asked whether their doctor at the antenatal clinic had asked them about their diet, bowel habits, and any anal discomfort (Fig. 4). According to respondents, antenatal clinics provide extremely poor information on this topic and do not delve into such an intimate issue.

 

Table 7. Proctological complaints before the current pregnancy

Parameter

Group 1

(n = 114), abs. (%)

Group 2

(n = 64, abs. (%)

Group 3

(n = 36), abs. (%)

p

These complaints were a concern before pregnancy

Yes

8 (7)

6 (9.4)

4 (11.1)

p1 = 0.576

p2 = 0.430

p3 = 0.782

No

66 (57,9)

38 (59.4)

26 (72.2)

p1 = 0.848

p2 = 0.124

p3 = 0.199

Difficult to answer

40 (35.1)

20 (31.3)

6 (16.7)

p1 = 0.604

p2 = 0.037

p3 = 0.111

 

 Table 8. Consultation with doctors regarding possible proctological complaints

Parameter

Group 1

(n = 114),

abs. (%)

Group 2

(n = 64),

abs. (%)

Group 3

(n = 36),

abs. (%)

p

The obstetrician-gynecologist/therapist asked questions about the nature of the diet, the nature of the stool, the presence of discomfort in the anus at the antenatal clinic

42 (36.8)

14 (21.9)

8 (22.2)

p1 = 0.040

p2 = 0.105

p3 = 0.968

Actions of an obstetrician-gynecologist/therapist in a women's clinic upon detection of the above complaints

The obstetrician-gynecologist/therapist did not provide recommendations regarding the existing complaints

110 (96.5)

62 (96.9)

30 (83.3)

p1 = 0.892

p2 = 0.006

p3 = 0.017

The obstetrician-gynecologist/therapist recommended visiting a proctologist

2 (1.8)

0 (0)

4 (11.1)

p1 = 0.287

p2 = 0.013

p3 = 0.007

The obstetrician-gynecologist/therapist independently prescribed treatment for hemorrhoids

2 (1,8)

2 (3.1)

2 (5.6)

p1 = 0.554

p2 = 0.218

p3 = 0.552

The obstetrician/gynecologist/therapist recommended waiting until the childbirth

0 (0)

0 (0)

0 (0)

p1 = 1.000

p2 = 1.000

p3 = 1.000

Parameter

Group 1

(n = 114),

abs. (%)

Group 2

(n = 64),

abs. (%)

Group 3

(n = 36),

abs. (%)

p

The patient had previously been examined by a proctologist

10 (8.8)

8 (12.5)

8 (22.2)

p1 = 0.429

p2 = 0.031

p3 = 0.204

It is important for the patient that the proctologist is a woman

32 (28)

8 (12.5)

18 (50)

p1 = 0.017

p2 = 0.015

p3 < 0.001

If the need was justified by a proctologist, the patient would agree to surgical treatment for hemorrhoids during pregnancy

76 (66.6)

42 (65.6)

18 (50)

p1 = 0.888

p2 = 0.072

p3 = 0.126

 

Fig. 4. Consultation with doctors

 

Conclusions

It was found in the conducted study that hemorrhoid symptoms were statistically more common in women in Group III, who, in turn, received progesterone hormonal therapy statistically longer – more than two trimesters. The most significant risk factors for hemorrhoid development in pregnant and postpartum women were: vaginal delivery; three or more pregnancies; long-term use of progestogens; a tendency toward constipation; and a family history of hemorrhoids and varicose veins. The problem of interdisciplinary monitoring of proctological complaints in pregnant and postpartum women by obstetricians and gynecologists remains relevant, since most doctors, unfortunately, do not provide recommendations regarding the existing symptoms in patients. The interdisciplinary problem of monitoring proctological complaints in pregnant women by obstetricians and gynecologists is also significant: in all three groups, a significant majority of doctors did not give recommendations regarding the existing rectal clinic in women.

×

About the authors

А. V. Romanovskaya

Saratov State Medical University named after V.I. Razumovsky

Email: maksim.polidanoff@yandex.ru
ORCID iD: 0000-0003-4736-2749

DSc (Medicine), Professor, Head of the Department of Obstetrics and Gynecology of the Faculty of Medicine, the Director of the Clinic of Obstetrics and Gynecology, Chief External Gynecology Consultant to the Ministry of Health of the Saratov Region

Russian Federation, Saratov

A. V. Parshin

Saratov State Medical University named after V.I. Razumovsky

Author for correspondence.
Email: maksim.polidanoff@yandex.ru
ORCID iD: 0000-0001-8793-4786

PhD (Medicine), Associate Professor, Associate Professor of the Department of Obstetrics and Gynecology of the Faculty of Medicine

Russian Federation, Saratov

I. А. Arzhaeva

Saratov State Medical University named after V.I. Razumovsky

Email: maksim.polidanoff@yandex.ru

PhD (Medicine), Associate Professor, Associate Professor of the Department of Obstetrics and Gynecology of the Faculty of Medicine

Russian Federation, Saratov

K. M. Karagyozyan

Saratov State Medical University named after V.I. Razumovsky

Email: maksim.polidanoff@yandex.ru

Assistant of the Department of Obstetrics and Gynecology of the Faculty of Medicine

Russian Federation, Saratov

References

  1. Howell E.A. Lack of patient preparation for the postpartum period and patients’ satisfaction with their obstetric clinicians. Obstet. Gynecol. 2010; 115 (2,1): 284–289.
  2. Shin G.H., Toto E.L., Schey R. Pregnancy and postpartum bowel changes: Constipation and fecal incontinence. American Journal of Gastroenterology 2015; 110: 521–529.
  3. Poskus T., Sabonyte-Balsaitiene Z., Jakubauskiene L. et al. Preventing hemorrhoids during pregnancy: a multicenter, randomized clinical trial. BMC Pregnancy Childbirth. 2022; 22: 374–377.
  4. Anne F. Peery et al. Risk Factors for Hemorrhoids on screening colonoscopy. PLoS One. 2015; 10 (9): 137–141.
  5. Abramowitz L., Sobhani I., Benifla J.L. et al. Anal fissure and thrombosed external hemorrhoids before and after delivery. Dis Colon Rectum 2002; 45 (5): 650–655.
  6. Juan C. Vazquez. Constipation, haemorrhoids, and heartburn in pregnancy. BMJ Clin Evid. 2010; 1411.
  7. Kuronen M., Hantunen S., Alanne L. et al. Pregnancy, puerperium and perinatal constipation – an observational hybrid survey on pregnant and postpartum women and their age-matched non-pregnant controls. BJOG 2021; 128 (6): 1057–1064.
  8. Bader Hamza Shirah et al. Hemorrhoids during pregnancy: Sitz bath vs. anorectal cream: A comparative prospective study of two conservative treatment protocols. Women and Birth. 2018; 31 (4): 272–277.
  9. Ferdinande K., Dorreman Y., Roelens K. et al. Anorectal symptoms during pregnancy and postpartum: A prospective cohort study. Colorectal Dis. 2018; 20 (12): 1109–1116.
  10. Quijano C.E, Abalos E. Conservative management of symptomatic and or complicated haemorrhoids in pregnancy and the puerperium. Cochrane Database of Systematic Reviews. 2005; 3: 004–077.
  11. Buzinskiene D., Sabonyte-Balsaitiene Z., Poskus T. Perianal diseases in pregnancy and after childbirth: frequency, risk factors, impact on women's quality of life and treatment methods. Front Surg 2002; 9: 788–823.
  12. Jakubauskas M., Poskus T. Evaluation and management of hemorrhoids. Dis Colon Rectum. 2020; 63: 420–424.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Method of delivery in patients of groups I–III

Download (32KB)
3. Fig. 2. Characteristics of hemorrhoid symptoms among women in labor, % of the number in the group

Download (64KB)
4. Fig. 3. Distribution of hemorrhoid symptoms among women in labor, %

Download (36KB)
5. Fig. 4. Consultation with doctors

Download (71KB)

Copyright (c) 2025 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 75489 от 05.04.2019 г
.